Next Article in Journal
Stabilin-1 in Tumor-Associated Macrophages: A Potential Therapeutic Target in Cancer Immunotherapy
Previous Article in Journal
Physiological Response Mechanisms of Triplophysa strauchii Under Salinity Stress
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance

1
Department of Biochemistry and Molecular Biology, Hengyang Medical School, University of South China, Hengyang 421001, China
2
Department of Medical Microbiology, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang Medical School, University of South China, Hengyang 421001, China
3
National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China
4
Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
*
Authors to whom correspondence should be addressed.
Biology 2025, 14(9), 1201; https://doi.org/10.3390/biology14091201
Submission received: 3 July 2025 / Revised: 19 August 2025 / Accepted: 26 August 2025 / Published: 5 September 2025
(This article belongs to the Section Microbiology)

Abstract

Simple Summary

Acinetobacter baumannii is often recognized for its resistance to antibiotics, posing a serious threat in healthcare environments. In this study, we investigated a clinical isolate, HKAB-1, that despite being highly sensitive to many antibiotics, exhibits pronounced virulence-associated traits. Compared to the reference strain ATCC 19606, HKAB-1 demonstrates enhanced survival in serum and under desiccating conditions. HKAB-1 also forms robust biofilm and displays greater motility, phenotypes associated with persistence and pathogenicity. Genomic and transcriptomic analyses revealed that HKAB-1 harbours active iron acquisition and heme utilization systems, which are highly responsive to host-like conditions. Moreover, we found that genes associated with biofilm formation were highly induced in biofilm-forming cells. Conversely, the expression of adeB was markedly reduced, potentially explaining its antibiotic susceptibility despite harbouring multiple resistance genes. These findings reflect a potential evolutionary trade-off in certain A. baumannii strains, favoring virulence-associated traits over the expression of antimicrobial resistance mechanisms. This result highlights the need for continuous genomic surveillance to monitor emerging virulent but drug-susceptible strains like HKAB-1, which may serve as reservoirs for resistance development under selective pressures.

Abstract

Acinetobacter baumannii is an opportunistic pathogen notable for multidrug resistance and environmental persistence. We characterized a clinical isolate, HKAB-1, which exhibits pronounced virulence-associated traits despite being highly susceptible to all tested antibiotics. HKAB-1 exhibited superior growth in MH2B, serum and desiccating conditions, robust biofilm formation, and active motility. Whole-genome sequencing identified two heme utilization clusters, multiple siderophore biosynthesis pathways, and other virulence-associated genes. Gene expression analysis revealed significant upregulation of heme utilization and siderophore biosynthetic gene clusters under serum exposure, indicating activation of iron uptake pathways under host-like conditions. Biofilm-associated genes, including bap, PNAG biosynthetic genes, and type IV pili components, were notably upregulated in biofilm-forming cells, supporting their role in driving the enhanced biofilm phenotype. Conversely, adeB, encoding a major RND efflux pump, was markedly downregulated, potentially explaining its drug-susceptible phenotype. Comparative genomic analysis highlighted differences in genes related to nutrient transport, metabolic pathways, and membrane biogenesis that may underpin its enhanced growth. These findings point to a potential trade-off between antibiotic resistance and virulence, underscoring the importance of monitoring antibiotic-susceptible yet highly virulent A. baumannii isolates as potential reservoirs for resistance evolution. Further investigation is warranted to elucidate the mechanisms underlying this phenotypic balance.

Graphical Abstract

1. Introduction

Acinetobacter baumannii is the most commonly isolated species of its genus in clinical settings and has become a model organism for studying multidrug resistance (MDR) [1]. In recent years, this pathogen has posed an escalating threat to global healthcare systems; the pathogen causes a wide range of severe nosocomial infections, including those of the respiratory tract, skin, urinary tract, wounds, and bloodstream [2]. The persistence of this bacterium in healthcare environments is largely attributed to its remarkable ability to withstand harsh conditions such as desiccation, disinfectants, and prolonged exposure to antimicrobials [3]. The genome plasticity of A. baumannii plays a central role in its exceptional resilience, enabling rapid adaptation to environmental pressures through the acquisition and horizontal transfer of exogenous genetic material [4]. The ability to integrate mobile genetic elements such as insertion sequences, transposons, and resistance islands further promotes genome rearrangement and the stable integration of resistance determinants [5,6]. Alarming trends over the past decade reveal a growing prevalence of pandrug-resistant A. baumannii strains [7], underscoring the urgent need to understand the genetic and physiological basis of its survival and pathogenicity.
Among various resistance mechanisms, overexpression of efflux pumps and reduced outer membrane permeability play pivotal roles in conferring antibiotic resistance in A. baumannii [8,9]. Of particular interest, A. baumannii intrinsically encodes a large repertoire of multidrug efflux pumps, which are categorized into single-component transporters and tripartite systems [10]. These efflux systems, acting independently or in synergy, actively extrude a wide variety of structurally and chemically diverse substrates, including antibiotics, biocides, dyes, and detergents, leading to reduced intracellular drug accumulation and elevated minimum inhibitory concentrations (MICs) [11,12].
Beyond antimicrobial resistance, the ability of A. baumannii to form biofilms on both biotic and abiotic surfaces, as well as its capacity for surface-associated motility, also contributes significantly to its success as a nosocomial pathogen [13,14]. These traits are particularly important in the colonization of medical devices and invasive procedures, facilitating persistent hospital-acquired infections [15]. Moreover, both biofilm formation and motility are thought to promote the dissemination and acquisition of resistance genes, further enhancing the organism’s adaptability and persistence in hospital environments [16,17]. Collectively, the interplay of biofilm formation, motility, and multidrug resistance underpins the remarkable ability of A. baumannii to persist and spread within clinical settings.
In this study, we characterized a clinical A. baumannii isolate, HKAB-1, which displays accelerated growth kinetics and pronounced virulence-associated phenotypes, such as increased biofilm formation, motility, desiccation tolerance, and serum resistance, despite being broadly susceptible to antibiotics. Whole-genome sequencing identified HKAB-1 as sequence type ST392 and revealed the presence of multiple putative virulence factors, including the hemO gene cluster and heme utilization cluster 1. Comparative genomic analysis highlighted differences in genes involved in nutrient transport, metabolic pathways, and membrane biogenesis that may contribute to enhanced growth in HKAB-1. Notably, the expression of adeB was significantly repressed in HKAB-1, potentially accounting for its drug-susceptible phenotype despite harbouring multiple resistance determinants. Furthermore, under biofilm conditions, genes encoding the biofilm-associated protein Bap, polysaccharide poly-N-acetylglucosamine (PNAG) biosynthetic genes and type IV pili (T4P) components were highly induced, supporting their role in HKAB-1 robust biofilm phenotype. These findings point to a potential evolutionary trade-off between antibiotic resistance and virulence, underscoring the need to re-evaluate the clinical significance of antibiotic-susceptible A. baumannii in infection control and resistance surveillance. Further studies are warranted to elucidate the molecular mechanisms underpinning this phenotype balance.

2. Methods and Materials

2.1. Sample Collection and Bacterial Isolation

The sputum sample from a patient with a left-sided heart failure suspected to have a bacterial infection was collected for bacterial remuneration analysis. The samples were spread on blood agar and incubated at 37 °C overnight. The pure cultures were stored at −80 °C till further processing.

2.2. Growth Curve Measurement in MH2B

Colonies of A. baumannii were grown in Mueller Hinton II Broth (MH2B) liquid medium (Solarbio Science & Technology Co., Ltd., Beijing, China) at 37 °C for 16–18 h. Cultures were inoculated into fresh 120 mL MH2B medium at an OD600 of 0.05 and cultured at 37 °C with shaking at 150 rpm. The readout of OD600 was used to plot the bacterial growth curves by the “baranyi_without_lag” model using the “nlsMicrobio” package in R 4.3.3 (R Foundation, Vienna, Austria) [18,19].

2.3. Growth Curve Analysis in Bovine Serum Albumin

Overnight cultures were washed twice with 0.85% NaCl and inoculated into 150 μL of either MH2B liquid medium or 100% bovine serum albumin (Bio-Channel Biotechnology Co., Ltd., Nanjing, China) in a polystyrene, U-bottom 96-well plate (Chengdu Anqite Medical Co., Ltd., Chengdu, China) at an initial OD600 of 0.004. OD600 was recorded every 20 min for 16 h at 37 °C with agitation (linear amplitude: 2 mm) using Tecan Infinite M200 Pro Microplate Reader (Tecan, Männedorf, Switzerland). Growth curves were modelled using either the modified Gompertz model “gompertzm” or the Baranyi and Roberts model without a maximum population parameter “baranyi_without_Nmax” via the “nlsMicrobio” package in R 4.3.3 (R Foundation, Vienna, Austria) [18,19].

2.4. Measurement of Minimal Inhibition Concentration

Measurement of minimal inhibition concentration was performed as previously described [20]. Briefly, overnight cell cultures of A. baumannii strains were diluted to OD600 of 0.02 in fresh MH2B liquid medium, and 30 μL cultures were inoculated into 120 μL of serial 2-fold substrate dilutions in MH2B liquid medium in a polystyrene, U-bottom 96-well plate. The microtiter plates were incubated at 37 °C for 16 h with 180 rpm and the OD600 was Tecan Infinite M200 Pro Microplate Reader (Tecan, Männedorf, Switzerland). The MIC was defined as the lowest antibiotic concentration at which the OD600 value was below 0.1.

2.5. Biofilm Formation Assay

Biofilm formation assay was determined as previously described with slight modification [21]. Briefly, overnight cell cultures of A. baumannii strains were inoculated into 5 mL polystyrene tubes containing 1 mL of LB medium at an initial OD600 of 0.05 and statically incubated at 30 °C or 37 °C for 24 h. Bacterial growth in the liquid culture was determined by OD600. Subsequently, the supernatant of bacterial cultures was discarded, and the biofilm cells were rinsed with distilled water three times and then stained with 0.1% crystal violet for 20 min at room temperature. The crystal violet staining solution was discarded, the tubes were again rinsed three times with distilled water, and the stained biofilm cells were solubilized with absolute ethanol. The solubilized biofilm cells were quantified at OD595. Biofilm formation was expressed as the OD595/OD600 ratio to normalize the total bacterial growth.

2.6. Motility Assays

Both swarming and twitching motility assays were determined as previously described with slight modification [22]. For swarming assay, overnight cultures were diluted to OD600 of 0.1, and a 2 μL drop was pipetted onto an LB medium consisting of 0.4% agar. The agar plates were incubated at 37 °C for 24 h. For twitching assay, overnight cultures were diluted to OD600 of 0.1, and a 2 μL drop of cultures was stab-inoculated through the LB medium consisting of 0.8% agar to form an interstitial colony between the petri dish and the agar medium. The agar plates were incubated at 37 °C for 24 h. After incubation, the agar was discarded, and the plates were stained with 0.2% crystal violet before visualization.

2.7. Desiccation Assay

Desiccation assay was assessed as previously described with slight modification [23]. Overnight cultures were grown in MH2B medium at 37 °C and then harvested and washed twice with 0.85% NaCl. The cell suspension was adjusted to an OD600 of 2.0 in the same buffer. Aliquots of 20 μL were pipetted onto cellulose acetate membrane filters (Hangzhou Special Paper Industry Co., Ltd., Hangzhou, China) (0.45 μm pore size) and air-dried under laminar flow. The dried membranes were then placed in uncovered petri dish inside airtight Glasslock containers (17.7 × 13.1 × 6.8 cm) (SGC Solutions Co., Ltd., Seoul, Republic of Korea) containing 30 g of Drierite desiccant (W A Hammond Drierite Co., Ltd., Xenia, OH, USA) to maintain a controlled relative humidity of 20 ± 3%. The containers were incubated at 24 °C. For viable cell counts at day 0, membranes were transferred into 2 mL tubes containing 1 mL of 0.85% NaCl and gently vortexed for 5 min at room temperature. Serial dilutions were plated on LB agar to determine colony-forming units (CFUs).

2.8. Hemolysis and Protease Assays

Hemolysis assay was performed on a Columbia blood agar plate supplemented with 5% defibrinated horse blood (Chongqing Pangtong Medical Devices Co., Ltd., Chongqing, China) as previously described [24]. Briefly, 10 μL of overnight cultures adjusted to an OD600 of 2.5 were inoculated onto the blood agar plate and incubated at 37 °C for 48 h. Protease assay was conducted on skim milk agar plates (Shandong Tuopu Biol-Engineering Co., Ltd., Zhaoyuan, China), which were incubated at 37 °C for 24 h.

2.9. RNA Extraction

To evaluate the expression of virulence-associated and RND efflux pump genes, overnight cultures of A. baumannii strains were diluted to an initial OD600 of 0.05 in 25 mL of LB medium and incubated at 37 °C with shaking at 180 rpm until reaching an OD600 of 0.5–0.7. To assess the expression of genes associated with serum tolerance, A. baumannii cells grown in serum-containing medium and MH2B (as the control) were harvested at an OD600 of 0.5–0.7. A 500 μL aliquot of each culture was stabilized using RNAstore Reagent (Tiangen Biotech Co., Ltd., Beijing, China). Total RNA was extracted using the RNAprep Pure Bacteria Kit (Tiangen Biotech Co., Ltd., Beijing, China). To determine the expression of biofilm-associated genes, biofilms from four technical replicates of the same biological sample were pooled and resuspended in RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany). RNA extraction was conducted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). The concentration and purity of RNA were determined using TGem Pro spectrophotometer (Tiangen Biotech Co., Ltd., Beijing, China).

2.10. Reverse Transcription qPCR

Reverse transcription was performed using the FastKing gDNA Dispelling RT SuperMix II (Tiangen Biotech Co., Ltd., Beijing, China) with 500 ng of total RNA as template. Quantitative PCR (qPCR) was conducted on an Applied Biosystems StepOnePlus (Applied Biosystems, Foster City, CA, USA) or Bio-Rad CFX Connect (Bio-Rad Laboratories, Hercules, CA, USA) thermal cycler using 2× Universal SYBR Green Fast qPCR Mix (AbClonal Technology, Woburn, MA, USA) with 400 ng of total cDNA per reaction. Primer sequences are listed in Table S1, with rpoB used as the reference gene. Gene expression analysis was conducted as previously described [25]. ΔCT values were calculated as CT(rpoB) − CT(target gene). Differences in mean ΔCT values between “treatment” (e.g., serum, biofilm, or HKAB-1) and “control” groups (e.g., LB or ATCC 19606) were analyzed using an analysis of variance (ANOVA) model implemented in R version 4.4.1 (R Foundation, Vienna, Austria) [19], incorporating Gene and Gene:Treatment interaction term. Tukey’s honestly significant difference (HSD) test was applied to determine statistically significant differences in gene expression between groups.

2.11. Extraction of Genomic DNA and Genome Sequencing

The genomic DNA was sheared to an average size of 350 bp using the Covaris LE220R-plus system (Covaris, Woburn, MA, USA) and then end-polished, A-tailed, and ligated to full-length Illumina adapters. The constructed libraries were sequenced on Illumina platforms (Illumina, San Diego, CA, USA) with 2 × 150 bp paired-end reads by Novogene Bioinformatics Technology Co., Ltd. (Beijing, China). Quality control and trimming of paired-end reads were performed using Trimmomatic v0.39 (Usadel Lab, RWTH Aachen University, Aachen, Germany) [26]. De novo assembly was performed using SPAdes v3.15.5 (Algorithmic Biology Laboratory, St. Petersburg Academic University, Russian Academy of Sciences, St. Petersburg, Russia) [27], resulting in 72 contigs. Contig annotation was carried out using the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) pipeline [28]. All contigs equal to or longer than 500 bp were successfully scaffolded using Multi-CAR (Algorithm and Bioinformatics Laboratory, Department of Computer Science, National Tsing Hua University, Republic of China) [29], which employs multiple reference genomes to arrange and orient contigs, resulting in a chromosomal assembly. Average nucleotide identity (ANI) analysis was calculated using online ANI calculator (https://www.ezbiocloud.net/tools/ani, accessed on 30 May 2025), employing OrthoANI algorithm [30].

2.12. Genome Annotation and Analysis

Genomes were analyzed for loci associated with antimicrobial resistance using Abricate v.1.01 (https://github.com/tseemann/abricate, Seemann Lab, University of Melbourne, Melbourne, Australia, accessed on 6 April 2025), with reference to the MEGARes v.2.0 (Microbial Ecology Group; Colorado State University, Texas A&M University, University of Florida, University of Minnesota, West Texas A&M University, Canyon, TX, USA) and Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT) v6 (Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France) [31,32]. Virulence factors and prophage sequences of A. baumannii HKAB-1 were analyzed with VFDB v2022 (NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China) [33] and PHASTEST v1.0.1 (Wishart Lab, Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada) [34], respectively. Genome map was created using Proksee v1.3.0 (Stothard Research Group, Agriculture, Food & Nutritional Science, University of Alberta, Edmonton, AB, Canada) [35]. Multilocus sequence typing (MLST) analysis was conducted using PubMLST (https://pubmlst.org, accessed on 30 May 2025) [36]. The capsular polysaccharide (CPS) locus (KL) and lipooligosaccharide outer core locus (OCL) of the HKAB-1 strain were identified using Kaptive Web v1.3.0 (Melbourne eResearch Group, University of Melbourne, Melbourne, Australia) with reference to the A. baumannii database [37]. The core-genome phylogenetic tree of A. baumannii HKAB-1 and representative Acinetobacter strains was constructed using annotated genome assemblies (GFF3 format) processed with Roary v3.13.0 (Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK) [38] to identify core genes. Multiple sequence alignment was performed using MAFFT v7.526 (Immunology Frontier Research Center, Osaka University, Osaka, Japan) [39], and phylogenetic inference was carried out with RAxML-NG v1.2.2 (Computational Molecular Evolution Group, Heidelberg Institute for Theoretical Studies, Heidelberg, Germany) [40] under the GTR + G model with 1000 bootstrap replicates.

3. Results

3.1. Strain Collection and Identification

A patient with left-sided heart failure and clinical signs consistent with a bacterial respiratory infection was admitted to the hospital. A bacterial isolate, designated HKAB-1, was recovered from the patient’s sputum following culturing on a Columbia blood agar plate supplemented with 5% defibrinated horse blood. No hemolytic was observed on the agar plate (Figure S1A). Based on preliminary phenotypic characteristics, the isolate was presumptively identified as A. baumannii. The patient exhibited multiple high-risk factors, including older age, severe cardiac dysfunction, and multi-organ dysfunction. In accordance with hospital treatment protocols, a seven-day course of piperacillin–tazobactam was initiated as empiric antimicrobial therapy. Following completion of the antibiotic regimen, the patient showed marked improvement in respiratory symptoms. By the ninth day of hospitalization, cardiac examination revealed normal heart sounds with no pathological murmurs across all valve areas, while pulmonary auscultation detected a few dry rales in both lungs. Given the clinical improvement, the patient was deemed fit for discharge. The isolate was subsequently referred to the Department of Medical Microbiology, Hengyang Medical School, University of South China, for molecular identification and phenotypic characterization.

3.2. HKAB-1 Is More Susceptible to a Broad Range of Antibiotics

In recent years, infections associated with A. baumannii have emerged as a significant concern in clinical settings, primarily due to their multidrug resistance phenotype [1]. Therefore, the antibiotic susceptibility profile of the clinical isolate HKAB-1 was evaluated relative to the laboratory strain ATCC 19606 to delineate strain-specific resistance patterns. Unexpectedly, HKAB-1 displayed greater susceptibility to most of the tested antibiotics compared to the reference strain ATCC 19606, with the exception of oxacillin (2-fold difference, MIC: 512 μg/mL) and rifampicin (2-fold difference, MIC: 4 μg/mL) (Table 1). Notably, HKAB-1 demonstrated significantly enhanced susceptibility, with 4- to 8-fold lower MIC for amikacin, azithromycin, ciprofloxacin, doripenem, tetracyclines, and tobramycin and up to 16-fold reduction in MIC for amoxicillin and tigecycline (Table 1).

3.3. HKAB-1 Exhibits Enhanced Biofilm Formation and Serum Resistance

The persistence of A. baumannii in clinical settings is largely attributed to its ability to form biofilm, which is a key virulence factor in infections [41,42]. To investigate these traits, we evaluated the capability to form biofilm and serum resistance of the HKAB-1 strain. To ensure accurate normalization in the biofilm assay, we first analyzed the growth kinetics of the clinical isolate HKAB-1 and the laboratory strain ATCC 19606 in MH2B medium. The HKAB-1 strain exhibited a higher growth rate in MH2B compared to ATCC 19606, with maximum specific growth rates (μmax) of 0.87 ± 0.03 h−1 and 0.63 ± 0.02 h−1 (unpaired Student’s t-test, p < 0.005), respectively (Figure 1A,B). Consistently, OD600 measurements at the 5 h time point were also higher for HKAB-1, with mean OD600 values of 1.57 ± 0.07 for ATCC 19606 and 1.91 ± 0.07 for HKAB-1 (unpaired Student’s t-test, p < 0.05) (Figure 1C).
Given the significant differences in growth dynamics, biofilm quantification using crystal violet staining was normalized to the OD600 of the corresponding statically incubated planktonic cultures to ensure comparability and accuracy. Notably, HKAB-1 formed slightly more biofilm at 37 °C than at 30 °C, although the difference was not statistically significant (unpaired Student’s t-test, p = 0.11), whereas ATCC 19606 showed no temperature-dependent variation in biofilm formation (Figure 1E). Interestingly, HKAB-1 demonstrated a significantly greater capacity for biofilm formation than ATCC 19606 at 30 °C (unpaired Student’s t-test with Welch’s correction, p < 0.05), whereas no notable difference was observed between the strains at 37 °C (Figure 1E).
Clinical Acinetobacter spp are known to exhibit high resistance to serum [43]. To assess the survival of the HKAB-1 strain in bovine serum albumin (BSA), we monitored the growth of both A. baumannii strains in BSA and MH2B using a polystyrene, U-bottom 96-well plate. As anticipated, HKAB-1 showed enhanced growth in MH2B compared to ATCC 19606 (Figure 1A,D), with mean OD600 values at the 16 h time point of 1.03 ± 0.01 for HKAB-1 and 0.85 ± 0.01 for ATCC 19606 (unpaired Student’s t-test, p < 0.005) (Figure 1D). Remarkably, HKAB-1 also demonstrated robust growth in 100% BSA, whereas ATCC 19606 was highly susceptible to BSA, with mean OD600 values of 0.57 ± 0.01 and 0.19 ± 0.02, respectively (unpaired Student’s t-test, p < 0.005) (Figure 1D). These findings highlight the enhanced adaptability of HKAB-1 under both nutrient-rich and serum-based conditions (Figure 1).

3.4. HKAB-1 Exhibits Enhanced Motility

Surface-associated motility has been recognized as a common trait among clinical isolates of A. baumannii [13]. To evaluate the motility of clinical isolate HKAB-1, we determined the swarming and twitching motility of both HKAB-1 and ATCC 19606 on semi-solid agar. After 24 h of incubation, HKAB-1 exhibited markedly greater swarming motility on the surface of agar and twitching motility at the agar–plastic interphase compared to the laboratory strain, with mean diameter of 2.8 ± 0.1 cm and 2.1 ± 0.1 cm (unpaired Student’s t-test, p < 0.005), respectively (Figure 2A–D). Congruent to previous findings [44], ATCC 19606 showed no motility on semi-solid media (Figure 2A–D).

3.5. HKAB-1 Tolerates Desiccation

Previous studies have shown that biofilm formation significantly enhances desiccation tolerance in A. baumannii, albeit potentially at the cost of reduced antibiotic resistance [45]. We hypothesized that the high antibiotic susceptibility and enhanced biofilm-forming ability of the HKAB-1 strain might confer improved tolerance to prolonged desiccation. Consistent with this hypothesis, desiccation resulted in a 66.3% reduction in viable HKAB-1 cells compared to the initial inoculum (Tukey’s HSD test, p < 0.005), whereas the viability of ATCC 19606 dropped to nearly undetectable levels after just one day of incubation (Figure 2E). Notably, after four days of desiccation, HKAB-1 retained approximately 15.4% viability (Tukey’s HSD test, p < 0.005) (Figure 2E), underscoring its enhanced desiccation resistance.

3.6. Genomic Context of A. baumannii HKAB-1 Strain

To explain the differences in antibiotic sensitivity between the clinical isolate and the ATCC 19606 strain, whole-genome sequencing of HKAB-1 was performed, and the average nucleotide identity (ANI) analysis [30] revealed that the isolate shared 97.88% identity with A. baumannii (NCBI accession CP059040), confirming species-level classification. The assembled genome has a total length of 3,758,367 bp and consists of a single circular chromosome (Figure 3A). Further validation of species identity and phylogenetic relationships was performed through core-genome analysis incorporating publicly available Acinetobacter genomes. Indeed, HKAB-1 clusters within the A. baumannii clade, demonstrating close evolutionary relatedness to clinically relevant strains such as AB030 (Figure 3B). Notably, no detectable plasmids were detected. The overall G + C content is 38.92%. Genome annotation predicted a total of 3559 genes, including 3488 coding sequences (CDSs) and 71 RNA genes, comprising 4 rRNAs and 63 tRNAs (Table 2). Among the 3488 predicted CDSs, 3446 protein-coding genes were assigned to 21 functional categories based on the COG database (Figure S2). Moreover, a considerable number of genes were categorized as unknown function (19.47%), suggesting that further analysis is needed to elucidate their functions. In silico MLST identified HKAB-1 as belonging to sequence type ST392 (Table S2) according to the Pasteur scheme [46]. Notably, ST392 has only been reported once previously, from a single isolate in Taiwan in 2010, raising questions about its geographic distribution and potential emergence.

3.7. Comparative Analysis of Genes Associated with Antimicrobial Resistance

Antimicrobial resistance gene profiling using ABRicate (https://github.com/tseemann/abricate, accessed on 6 April 2025), with reference to the MEGARes 2.0 and Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT), identified a total of 27 and 28 open reading frames (ORFs) putatively associated with resistance genes in the HKAB-1 and ATCC 19606 strains (Table 3) [31,32]. Of the 27 resistance genes, 21 are associated with the efflux pumps, including 10 ORFs from the resistance nodulation cell division (RND) family, 4 ORFs encoding putative major facilitator superfamily (MFS) family, 2 ORFs from the multidrug and toxic efflux (MATE) family, 1 ORF from the small multidrug resistance (SMR) family, and 5 ORFs encoding putative transcriptional regulators. The remaining 6 ORFs are associated with antibiotic inactivation, comprising 5 β-lactamase encoding genes and 1 gene encoding an aminoglycoside nucleotidyltransferase (ant(3)-IIa). Similar to ATCC 19606, HKAB-1 lacks the gene encoding outer membrane protein adeC gene in its genome. The absence of adeC from the adeAB loci in Acinetobacter genome is unprecedented, as AdeAB could recruit another outer membrane protein AdeK to form a functional tripartite complex [47]. Interestingly, HKAB-1 harbours a comparable number of antimicrobial resistance genes to ATCC 19606 but exhibits increased susceptibility to all tested antibiotics.

3.8. Comparative Analysis of Genes Associated with Virulence Factors

Since the HKAB-1 strain exhibited higher virulence, including higher biofilm formation, motility, and serum resistance, compared to ATCC 19606, we evaluated the genetic background of different virulence traits between HKAB-1 and ATCC 19606 strains. The HKAB-1 genome encodes 106 ORFs associated with virulence factors, which are categorized into seven major functional families comprising adherence, biofilm formation, phospholipases, immune evasion, iron uptake, regulatory functions, and serum resistance (Table S3). In comparison, the ATCC 19606 genome contains 95 virulence-associated ORFs, lacking key heme utilization genes, including the hemO gene cluster (ACP71R_11060–ACP71R_11105) and heme utilization cluster 1 (ACP71R_06965–ACP71R_07025), both of which are present in HKAB-1 (Table S3). Additionally, the genome also harbours two putative prophage regions with high sequence similarity to PHAGE_Acinet_Bphi_B1251_NC_019541 (Figure 3A). The first prophage is an intact prophage spanning 43.7 Kb (positions 2,159,893 to 2,203,690 bp) with a GC content of 38.67%. The second prophage is an incomplete prophage, 30.9 Kb in length, located between positions 1,930,574 and 1,961,551 bp, with a GC content of 35.65%.
In addition to virulence factors identified through the VFDB, the capsular polysaccharide (KL) locus is recognized as a critical determinant of A. baumannii pathogenicity [48]. The HKAB-1 strain carries the KL107 locus, located between the ACP71R_14980 encoding a putative FKBP-type peptidyl-prolyl cis-trans isomerase (fkpA) and lldP genes, and on the one hand, the OCL3 locus, situated between ACP71R_00345 (encoding a hypothetical protein) and the ACP71R_00295 encoding putative branched-chain amino acid transaminase (ilvE) genes. These loci are responsible for the biosynthesis and export of capsular polysaccharide (CPS) and outer core locus (OCL), respectively. Notably, OCL3 of the HKAB-1 strain differs from the more common OCL configurations, which typically reside between ilvE and aspS [49].

3.9. Relative Expression of Efflux Pump and Virulence-Associated Genes

To investigate the functional relevance of efflux pumps and virulence-associated genes in antibiotic resistance and pathogenicity, we quantified the expression levels of these genes under relevant phenotypic conditions using RT-qPCR. No significant differences were detected in the transcription of adeG and adeJ between HKAB-1 (adeG: ∆CT = −9.45 ± 0.15; adeJ: ∆CT = −1.97 ± 0.15) and ATCC 19606 (adeG: ∆CT = −9.42 ± 0.15; adeJ: ∆CT = −1.49 ± 0.15) in LB medium (Figure 4A, see x-axis). In contrast, adeB was markedly downregulated in HKAB-1 (ΔΔCT = −7.27 ± 0.21; fold change = 0.0065), potentially contributing to its antibiotic-susceptible phenotype despite harbouring multiple resistance genes.
Given the roles of biofilm-associated protein Bap, Csu pili, PNAG biosynthesis, and T4P in biofilm formation and twitching motility (Table S3) [50,51,52,53], we examined their transcriptional profiles in HKAB-1. ATCC 19606 exhibited relatively low expression, except for csuC (bap: ∆CT = −4.95 ± 0.32; csuC: ∆CT = −1.22 ± 0.32; pgaB: ∆CT = −7.58 ± 0.32; pilA: ∆CT = −10.04 ± 0.32; pilO: ∆CT = −8.17 ± 0.32) (Figure 4B, see x-axis). No appreciable transcriptional differences were observed for csuC encoding a chaperone involved in Csu pili assembly and pgaB encoding a deacetylase in PNAG biosynthesis across the two strains (Figure 4B). However, bap and T4P-specific genes, including pilA encoding a putative pilin and pilO encoding a T4P biogenesis protein, were significantly upregulated in HKAB-1 (bap: ΔΔCT = 3.03 ± 0.45; fold change = 8.14; pilA: ΔΔCT = 5.54 ± 0.45; fold change = 46.54; pilO: ΔΔCT = 2.42 ± 0.45; fold change = 5.34) (Figure 4B), consistent with its robust biofilm and motility phenotypes.
To further assess the functional role of biofilm-associated genes in biofilm development, we compared their expression between biofilm-associated cells and planktonic cultures. Consistent with our earlier results (Figure 4B), csuC showed no appreciable transcriptional difference between the two conditions (Figure 4C). Unexpectedly, pgaB, which was expressed at low levels in planktonic cells (Figure 4B), was strongly induced in biofilm cells (ΔΔCT = 5.55 ± 0.43; fold change = 46.79), supporting a key role for PNAG biosynthesis in biofilm formation (Figure 4C). As anticipated, bap and T4P-specific genes (pilA and pilO) were further upregulated in biofilm-associated cells compared to planktonic cells (bap: ΔΔCT = 2.06 ± 0.43; fold change = 4.17; pilA: ΔΔCT = 2.73 ± 0.43; fold change = 6.62; pilO: ΔΔCT = 3.77 ± 0.43; fold change = 13.60) (Figure 4B,C). Intriguingly, both adeB and adeG, RND efflux pump genes expressed at relatively low levels in planktonic HKAB-1 (Figure 4A), were notably induced in biofilm-associated cells (adeB: ΔΔCT = 7.88 ± 0.43; fold change = 236.19; adeG: ΔΔCT = 7.54 ± 0.43; fold change = 185.98), whereas adeJ expression remained unchanged (Figure 4C). Given previous reports linking siderophore biosynthesis to biofilm development [54], we also examined siderophore-related genes and found that both basA (acinetobactin cluster) and bfnL (fimsbactin cluster) were strongly induced in biofilm cells (basA: ΔΔCT = 6.05 ± 0.43; fold change = 66.43; bfnL: ΔΔCT = 3.84 ± 0.43; fold change = 14.33) (Figure 4C), indicating a contributory role in biofilm development. Collectively, the pronounced upregulation of bap and T4P genes in HKAB-1 relative to ATCC 19606, together with their further induction in biofilm conditions and the concurrent activation of PNAG, RND efflux pumps, and siderophore systems, suggests a synergistic network of factors driving the robust biofilm phenotype of HKAB-1.
The heme utilization cluster plays a crucial role in bacterial survival under serum conditions [55]. Given that HKAB-1 harbours heme utilization genes, which are absent in ATCC 19606, we evaluated the regulatory response of iron acquisition systems to serum exposure by analyzing the expression of genes involved in heme uptake and siderophore biosynthesis. Under standard growth conditions in MH2B, expression of heme acquisition genes, including hemO, encoding a putative heme oxygenase and ACP71R_07005, a predicted TonB-dependent receptor from heme utilization cluster 1, along with siderophore biosynthesis genes such as basA and bfnL, remained relatively low (Figure 4D; see x-axis). Under exposure to serum, all four genes were significantly activated (hemO: ∆∆CT = 9.13 ± 0.42; fold change = 558.50; ACP71R_07005: ∆∆CT = 1.89 ± 0.42; fold change = 3.71; bfnL: ∆∆CT = 6.05 ± 0.42; fold change = 66.29; basA: ∆∆CT = 4.32 ± 0.42; fold change = 19.96) (Figure 4D), suggesting that iron acquisition pathways are strongly induced under host-mimicking conditions.

4. Discussion

The high antibiotic susceptibility phenotype of HKAB-1 is congruent with previous observations that certain A. baumannii and Acinetobacter lwoffii isolates, despite being susceptible to antibiotics, can still cause a broad range of infections [56]. Notably, while A. lwoffii is generally considered antibiotic-susceptible and carries relatively few resistance genes, it has recently emerged as a prevalent cause of infections, particularly in neonatal intensive care units, and is increasingly associated with MDR phenotypes [56,57]. These findings suggest that antibiotic susceptibility does not necessarily preclude the capacity for nosocomial outbreaks and that Acinetobacter spp. may still acquire resistance determinants under clinical selection pressure. Consistent with this observation, genome analysis of HKAB-1 revealed the presence of various antibiotic resistance genes, including those encoding clinically significant RND efflux pumps, which are key contributors to MDR phenotypes in A. baumannii [58]. Intriguingly, the transcript levels of adeB is relative low in HKAB-1 (∆CT = −10.11 ± 0.15) compared to ATCC 19606 (∆CT = −2.85 ± 0.15) (Figure 4A, see x-axis), and comparative gene analysis between HKAB-1 and ATCC 19606 indicates downregulation of adeB in HKAB-1 (ΔΔCT = −7.27 ± 0.21; fold change = 0.0065) (Figure 4A). In contrast, no significant differences in expression levels of adeG and adeJ were observed under standard growth medium (Figure 4A). These findings suggest that reduced adeB expression is likely to account for the increased susceptibility of HKAB-1, as this efflux pump is critical in multidrug resistance in clinical A. baumannii isolates [8,59]. Moreover, reduced activity or downregulation of other resistance mechanisms, such as β-lactamases or non-RND efflux systems, may also contribute to the observed antibiotic susceptibility phenotype. Together, these findings indicate that although HKAB-1 currently remains antibiotic-susceptible, it harbours the genetic potential to express and activate resistance traits under appropriate selective pressures, warranting careful monitoring of such strains in clinical settings.
The ability of HKAB-1 to cause infection in the host led us to hypothesize that this strain may exhibit enhanced virulence phenotypes compared to the laboratory strain ATCC 19606. Consistent with this hypothesis, phenotypic characterization revealed that HKAB-1 demonstrates superior growth in serum and under desiccated conditions and the ability to form biofilm; it also displays both swarming and twitching motility (Figure 1 and Figure 2), while lacking hemolytic and proteolytic activities (Figure S1), traits collectively associated with virulence in A. baumannii [13,41,42,43,60]. Previous studies have suggested that the acquisition of MDR often incurs a fitness cost, including impaired growth and reduced tolerance to environmental stressors, while increased biofilm formation may offset antibiotic susceptibility in A. baumannii [45,61]. In line with these observations, HKAB-1 displays increased desiccation resistance and robust biofilm-forming capacity despite being highly susceptible to all tested antibiotics (Figure 1E and Figure 2E). Notably, HKAB-1 also exhibited higher metabolic capacity, as evidenced by faster growth kinetics and greater biomass yields (higher OD600 readings) in both MH2B and serum-based media (Figure 1A,D). Comparative analysis of annotated genes across categories of clusters of orthologous groups (COGs) revealed that HKAB-1 possesses more genes in several growth-related functions, including energy production and conversion (C), amino acid metabolism (E), inorganic ion transport (P), cell envelope biogenesis (M), and carbohydrate metabolism (G) (Figure S2). The enrichment of these COGs suggests an enhanced modulation of nutrient uptake, metabolic pathway genes, and membrane synthesis, which may collectively reduce physiological bottlenecks and enhance growth efficiency. Of particular note, we observed significant downregulation of the adeB efflux pump gene in HKAB-1 (Figure 4A). Given the energetic cost associated with resistance mechanisms [62], reduced adeB expression may alleviate metabolic burden, thereby contributing to improved growth. Together, these findings may support a model in which decreased antimicrobial resistance is offset by enhanced virulence traits and environmental fitness. The molecular mechanisms underlying this trade-off remain unclear and warrant further investigation.
Further genomic analysis revealed that HKAB-1 harbours the hemO gene cluster (ACP71R_11060–ACP71R_11105), as well as an additional heme utilization cluster 1 (ACP71R_06965–ACP71R_07025) (Table S3). The hemO cluster, frequently found in MDR epidemic strains, has been implicated in increased virulence [55,63] and is thought to enhance bacterial survival in serum by facilitating iron acquisition from heme [55]. In agreement with these findings, we observed significant upregulation of hemO and ACP71R_07005, which encodes a heme oxygenase and a putative TonB-dependent receptor, respectively, in response to serum exposure (Figure 4D). Moreover, genes involved in the biosynthesis of the siderophores acinetobactin (basA) and fimsbactin (bfnL) were also markedly upregulated under these conditions (Figure 4D). These results indicate that both heme utilization and siderophore-mediated iron acquisition are critical for bacterial fitness in serum. We posit that the concurrent presence of hemO cluster, heme utilization cluster 1, and multiple siderophore systems contributes to the superior survival of HKAB-1 in serum, which contains limited free iron but is rich in heme-bound iron [64]. Although ATCC 19606 has been shown to utilize heme, earlier studies employed higher heme concentrations than those found in serum [65], potentially explaining its reduced growth under these conditions.
T4P is key virulence factor in A. baumannii, mediating host cell adhesion, biofilm formation, and twitching motility [53]. PilN and PilO are highly conserved components of the PilMNOP inner membrane alignment subcomplex, and the proper heterodimerization of PilNO is crucial for T4P biogenesis [66]. Comparative genomic analysis revealed that the ATCC 19606 strain harbours a disrupted pilN gene (Table S3). The absence of a functional pilN likely compromises pilus assembly, contributing to its deficiencies in motility and biofilm formation. In contrast, all T4P in HKAB-1, including pilN, are intact (Table S3), consistent with its retained twitching motility and robust biofilm phenotype. Moreover, prior studies suggest that variation in pilA, which encodes the major pilin subunit, can influence pilin surface electrostatics and modulate pilus-associated functions in A. baumannii [44,53]. PilA variants in Acinetobacter diverge into glycosylated forms, with a C-terminal serine residue serving as a glycosylation site and non-glycosylated forms lacking this residue (Figure S3B). Glycosylation of PilA is mediated by a T4P-specific O-oligosaccharyltransferase tfpO located downstream of pilA [67]. While the functional impact of PilA glycosylation remains uncertain, strain-specific variants have been linked to distinct phenotypes [68]. For instance, the AB5075 variant is associated with twitching motility, whereas the ACICU variant promotes biofilm formation [53]. Phylogenetic analysis of PilA sequences from 19 A. baumannii strains revealed that HKAB-1 PilA forms a distinct clade, clustering more closely with variants from ACICU, NIPH-329, Ab44444, and OIFC137 than with AB5075, BIDMC57, or ATCC 19606 (Figure S3A). Notably, despite clustering with ACICU, HKAB-1 PilA lacks the terminal serine residue, placing it within the non-glycosylated subgroup (Figure S3). These findings suggest a potential strain-specific role for HKAB-1 PilA in modulating motility and biofilm formation. In addition, elevated expression of pilA and pilO in HKAB-1 supports the enhanced twitching motility and biofilm phenotypes observed in this strain (Figure 1E, Figure 2A,B and Figure 4C).
Moreover, HKAB-1 encodes bap, a biofilm-associated protein essential for biofilm development in A. baumannii [50], which is also present in ATCC 19606. The markedly elevated expression of bap and T4P genes (e.g., pilA and pilO) in HKAB-1, coupled with their further induction under biofilm conditions and the upregulation of PNAG biosynthesis (Figure 4B,C), likely underpins the molecular basis of its enhanced biofilm-forming capacity. Intriguingly, both AdeB and AdeG RND efflux pumps, expressed at low levels in planktonic cultures, were highly responsive to biofilm conditions (Figure 4A,C), implicating that RND efflux pumps play roles in biofilm maturation or maintenance [69]. Biofilm formation, mediated in part by Bap and RND efflux systems, is a critical virulence mechanism that facilitates A. baumannii persistence under hostile host and environmental conditions [41,69,70]. Previous studies have further suggested that biofilm production is often correlated with both antibiotic susceptibility and serum resistance. Specifically, high biofilm-producing isolates often exhibit lower resistance to antibiotics in planktonic culture but display greater resistance to host factors such as serum, as well as enhanced resistance to desiccation [15,42,45,71]. Collectively, the biofilm-forming capacity of HKAB-1 may confer a selective advantage under host-associated stress or antibiotic exposure and potentially promote the acquisition or persistence of multidrug resistance within biofilm communities.

5. Conclusions

Although A. baumannii HKAB-1 harbours a wide array of antimicrobial resistance genes, including clinically relevant putative β-lactamases, as well as multiple RND and MFS efflux pumps, the strain remains susceptible to all tested antibiotics. Notably, genome analysis also reveals the presence of diverse virulence factors and prophage sequences, indicating a genomic architecture favorable to pathogenicity. Specifically, HKAB-1 harbours heme utilization clusters and multiple biofilm-associated genes, contributing to its capability to survive in serum and to its enhanced biofilm formation compared to ATCC 19606. These findings highlight the critical need for continuous surveillance of A. baumannii clinical isolates in order to prevent the emergence and spread of resistance in strains harbouring extensive multidrug resistance determinants.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biology14091201/s1, Figure S1: Bacterial growth on Columbia blood agar supplemented with 5% defibrinated horse blood and Skim milk agar. Figure S2: Comparison of COG category gene counts between A. baumannii ATCC19606 and HKAB-1. Figure S3: Sequence alignment and phylogeny of A. baumannii PilA variants. Table S1: Primer sequences used for RT-qPCR. Table S2: Sequence typing of A. baumannii clinical isolate HKAB-1 (ST392) using PubMLST database according to Pasteur Scheme. Table S3: Predicted virulence factors of A. baumannii clinical isolate HKAB-1.

Author Contributions

Conceptualization, W.E.F. and H.-K.T.; methodology, W.E.F., J.H. and H.-K.T.; validation, W.E.F., W.H., X.X., J.H. and H.-K.T.; formal analysis, J.H. and H.-K.T.; investigation, W.E.F., W.H., X.X., J.H. and H.-K.T.; writing—original draft, H.-K.T.; writing—review and editing, W.E.F., J.H. and H.-K.T.; visualization, W.E.F., J.H. and H.-K.T.; supervision, W.E.F., J.H. and H.-K.T.; project administration, W.E.F. and H.-K.T.; funding acquisition, W.E.F. and H.-K.T. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the start-up package through the University of South China (221RGC012), the Hunan Provincial Natural Science Fund (2024JJ5326), and The Science and Technology Innovation Program of Hunan Province (2024RC9011).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Hengyang Central Hospital (Project identification: Molecular Epidemiology and Intervention Strategies for Hospital-Acquired Infections Caused by Carbapenem-resistant Gram-negative Bacteria) on 24 March 2025.

Informed Consent Statement

Informed consent for participation was obtained from all subjects involved in the study.

Data Availability Statement

The whole-genome sequencing project of A. baumannii HKAB-1 has been deposited at NCBI’s GenBank under BioProject accession number PRJNA1255546, BioSample accession number SAMN48147428, and nucleotide accession number CP191205. The raw sequences have been deposited in the SRA under the accession number SRX28891183.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

References

  1. Vila, J.; Martí, S.; Sánchez-Céspedes, J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 2007, 59, 1210–1215. [Google Scholar] [CrossRef]
  2. Dijkshoorn, L.; Nemec, A.; Seifert, H. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5, 939–951. [Google Scholar] [CrossRef] [PubMed]
  3. Fournier, P.E.; Richet, H.; Weinstein, R.A. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 2006, 42, 692–699. [Google Scholar] [CrossRef]
  4. Touchon, M.; Cury, J.; Yoon, E.J.; Krizova, L.; Cerqueira, G.C.; Murphy, C.; Feldgarden, M.; Wortman, J.; Clermont, D.; Lambert, T.; et al. The genomic diversification of the whole Acinetobacter genus: Origins, mechanisms, and consequences. Genome Biol. Evol. 2014, 6, 2866–2882. [Google Scholar] [CrossRef]
  5. Fournier, P.E.; Vallenet, D.; Barbe, V.; Audic, S.; Ogata, H.; Poirel, L.; Richet, H.; Robert, C.; Mangenot, S.; Abergel, C.; et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006, 2, e7. [Google Scholar] [CrossRef] [PubMed]
  6. Peleg, A.Y.; Seifert, H.; Paterson, D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21, 538–582. [Google Scholar] [CrossRef] [PubMed]
  7. Nowak, J.; Zander, E.; Stefanik, D.; Higgins, P.G.; Roca, I.; Vila, J.; McConnell, M.J.; Cisneros, J.M.; Seifert, H.; MagicBullet Working Group WP4. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J. Antimicrob. Chemother. 2017, 72, 3277–3282. [Google Scholar]
  8. Rumbo, C.; Gato, E.; López, M.; Ruiz de Alegría, C.; Fernández-Cuenca, F.; Martínez-Martínez, L.; Vila, J.; Pachón, J.; Cisneros, J.M.; Rodríguez-Baño, J.; et al. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2013, 57, 5247–5257. [Google Scholar] [CrossRef]
  9. Zgurskaya, H.I.; Löpez, C.A.; Gnanakaran, S. Permeability barrier of Gram-negative cell envelopes and approaches to bypass it. ACS Infect. Dis. 2015, 1, 512–522. [Google Scholar] [CrossRef]
  10. Verma, P.; Tiwari, M.; Tiwari, V. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors. Microb. Pathog. 2021, 152, 104766. [Google Scholar] [CrossRef]
  11. Foong, W.E.; Tam, H.K.; Crames, J.J.; Averhoff, B.; Pos, K.M. The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity. J. Antimicrob. Chemother. 2019, 74, 1192–1201. [Google Scholar] [CrossRef]
  12. Foong, W.E.; Wilhelm, J.; Tam, H.K.; Pos, K.M. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. J. Antimicrob. Chemother. 2020, 75, 1135–1139. [Google Scholar] [CrossRef]
  13. Skiebe, E.; de Berardinis, V.; Morczinek, P.; Kerrinnes, T.; Faber, F.; Lepka, D.; Hammer, B.; Zimmermann, O.; Ziesing, S.; Wichelhaus, T.A.; et al. Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii depends on 1,3-diaminopropane. Int. J. Med. Microbiol. 2012, 302, 117–128. [Google Scholar] [CrossRef]
  14. Orsinger-Jacobsen, S.J.; Patel, S.S.; Vellozzi, E.M.; Gialanella, P.; Nimrichter, L.; Miranda, K.; Martinez, L.R. Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces. Microbiology 2013, 159, 2594–2604. [Google Scholar] [CrossRef]
  15. Rodríguez-Baño, J.; Martí, S.; Soto, S.; Fernández-Cuenca, F.; Cisneros, J.M.; Pachón, J.; Pascual, A.; Martínez-Martínez, L.; McQueary, C.; Actis, L.A.; et al. Biofilm formation in Acinetobacter baumannii: Associated features and clinical implications. Clin. Microbiol. Infect. 2008, 14, 276–278. [Google Scholar] [CrossRef]
  16. Wilharm, G.; Piesker, J.; Laue, M.; Skiebe, E. DNA uptake by the nosocomial pathogen Acinetobacter baumannii occurs during movement along wet surfaces. J. Bacteriol. 2013, 195, 4146–4153. [Google Scholar] [CrossRef] [PubMed]
  17. Penesyan, A.; Nagy, S.S.; Kjelleberg, S.; Gillings, M.R.; Paulsen, I.T. Rapid microevolution of biofilm cells in response to antibiotics. NPJ Biofilms Microbiomes 2019, 5, 34. [Google Scholar] [CrossRef] [PubMed]
  18. Baty, F.; Delignette-Muller, M.L.; nlsMicrobio: Data Sets and Nonlinear Regression Models Dedicated to Predictive Microbiology. R package Version 0.0-1 2014. Available online: https://cran.r-project.org/web/packages/nlsMicrobio/nlsMicrobio.pdf (accessed on 16 April 2025).
  19. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021; Available online: https://www.R-project.org/ (accessed on 16 April 2025).
  20. Tam, H.K.; Malviya, V.N.; Foong, W.E.; Herrmann, A.; Malloci, G.; Ruggerone, P.; Vargiu, A.V.; Pos, K.M. Binding and transport of carboxylated drugs by the multidrug transporter AcrB. J. Mol. Biol. 2020, 432, 861–877. [Google Scholar] [CrossRef] [PubMed]
  21. Haney, E.F.; Trimble, M.J.; Cheng, J.T.; Vallé, Q.; Hancock, R.E.W. Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides. Biomolecules 2018, 8, 29. [Google Scholar] [CrossRef]
  22. Clemmer, K.M.; Bonomo, R.A.; Rather, P.N. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 2011, 15, 2534–2544. [Google Scholar] [CrossRef]
  23. Oda, Y.; Shapiro, M.M.; Lewis, N.M.; Zhong, X.; Huse, H.K.; Zhong, W.; Bruce, J.E.; Manoil, C.; Harwood, C.S. CsrA-controlled proteins reveal new dimensions of Acinetobacter baumannii desiccation tolerance. J. Bacteriol. 2022, 204, e0047921. [Google Scholar] [CrossRef]
  24. Tuttobene, M.R.; Pérez, J.F.; Pavesi, E.S.; Perez Mora, B.; Biancotti, D.; Cribb, P.; Altilio, M.; Müller, G.L.; Gramajo, H.; Tamagno, G.; et al. Light modulates important pathogenic determinants and virulence in ESKAPE pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus. J. Bacteriol. 2021, 203, e00566-20. [Google Scholar] [CrossRef] [PubMed]
  25. Foong, W.E.; Xiang, X.; Pos, K.M.; Tam, H.K. Molecular determinants of substrate specificity in the efflux pump CraA from Acinetobacter baumannii. Microbiol. Spectr. 2025, 13, e0111925. [Google Scholar] [CrossRef]
  26. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef] [PubMed]
  27. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjbelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef]
  28. Olson, R.D.; Assaf, R.; Brettin, T.; Conrad, N.; Cucinell, C.; Davis, J.J.; Dempsey, D.M.; Dickerman, A.; Dietrich, E.M.; Kenyon, R.W.; et al. Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): A resource combining PATRIC, IRD and ViPR. Nucleic Acids Res. 2023, 51, D678–D689. [Google Scholar] [CrossRef]
  29. Chen, K.T.; Chen, C.J.; Shen, H.T.; Liu, C.L.; Huang, S.H.; Lu, C.L. Multi-CAR: A tool of contig scaffolding using multiple references. BMC Bioinform. 2016, 17, 469. [Google Scholar] [CrossRef] [PubMed]
  30. Yoon, S.H.; Ha, S.M.; Lim, J.M.; Kwon, S.J.; Chun, J. A large-scale evaluation of algorithms to calculate average nucleotide identity. Antonie Van Leeuwenhoek 2017, 110, 1281–1286. [Google Scholar] [CrossRef]
  31. Gupta, K.; Padmanabhan, B.R.; Diene, S.M.; Lopez-Rojas, R.; Kempf, M.; Landraud, L.; Rolain, J.M. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob. Agents Chemother. 2014, 58, 212–220. [Google Scholar] [CrossRef]
  32. Bonin, N.; Doster, E.; Worley, H.; Pinnell, L.J.; Bravo, J.E.; Ferm, P.; Marini, S.; Prosperi, M.; Noyes, N.; Morley, P.S.; et al. MEGARes and AMR++, v3.0: An updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing. Nucleic Acids Res. 2023, 51, D744–D752. [Google Scholar]
  33. Chen, L.; Yang, J.; Yu, J.; Yao, Z.; Sun, L.; Shen, Y.; Jin, Q. VFDB: A reference database for bacterial virulence factors. Nucleic Acids Res. 2005, 33, D325–D328. [Google Scholar] [CrossRef]
  34. Wishart, D.S.; Han, S.; Saha, S.; Oler, E.; Peters, H.; Grant, J.R.; Stothard, P.; Gautam, V. PHASTEST: Faster than PHASTER, Better than PHAST. Nucleic Acids Res. 2023, 51, W443–W450. [Google Scholar] [CrossRef]
  35. Grant, J.R.; Enns, E.; Marinier, E.; Mandal, A.; Herman, E.K.; Chen, C.Y.; Graham, M.; Van Domselaar, G.; Stothard, P. Proksee: In-depth characterization and visualization of bacterial genomes. Nucleic Acids Res. 2023, 51, W484–W492. [Google Scholar] [CrossRef]
  36. Jolley, K.A.; Bray, J.E.; Maiden, M.C.J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their application. Wellcome Open Res. 2018, 3, 124. [Google Scholar] [CrossRef]
  37. Cahill, S.M.; Hall, R.M.; Kenyon, J.J. An update to the database for Acinetobacter baumannii capsular polysaccharide locus typing extends the extensive and diverse repertoire of genes found at and outside the K locus. Microb. Genom. 2022, 8, 000878. [Google Scholar] [CrossRef] [PubMed]
  38. Page, A.J.; Cummins, C.A.; Hunt, M.; Wong, V.K.; Reuter, S.; Matthew, T.G.; Holden, M.T.G.; Fookes, M.; Falush, D.; Keane, J.A.; et al. Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015, 31, 3691–3693. [Google Scholar] [CrossRef] [PubMed]
  39. Katoh, K.; Standley, D.M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 2013, 30, 772–780. [Google Scholar] [CrossRef]
  40. Kozlov, A.M.; Darriba, D.; Flouri, T.; Morel, B.; Stamatakis, A. RAxML-NG: A fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 2019, 35, 4453–4455. [Google Scholar] [CrossRef]
  41. Lee, H.W.; Koh, Y.M.; Kim, J.; Lee, J.C.; Lee, Y.C.; Seol, S.Y.; Cho, D.T.; Kim, J. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 2008, 14, 49–54. [Google Scholar] [CrossRef] [PubMed]
  42. Espinal, P.; Marti, S.; Vila, J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J. Hosp. Infect. 2012, 80, 56–60. [Google Scholar] [CrossRef]
  43. Magda, M.; Bettoni, S.; Laabei, M.; Fairley, D.; Russo, T.A.; Riesbeck, K.; Blom, A.M. Clinical isolates of Acinetobacter spp. are highly serum resistant despite efficient recognition by the complement system. Front. Immunol. 2022, 13, 814193. [Google Scholar] [CrossRef] [PubMed]
  44. Eijkelkamp, B.A.; Stroeher, U.H.; Hassan, K.A.; Papadimitrious, M.S.; Paulsen, I.T.; Brown, M.H. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol. Lett. 2011, 323, 44–51. [Google Scholar] [CrossRef]
  45. Greene, C.; Vadlamudi, G.; Newton, D.; Foxman, B.; Xi, C. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am. J. Infect. Control 2016, 44, e65–e71. [Google Scholar] [CrossRef]
  46. Diancourt, L.; Passet, V.; Nemec, A.; Dijkshoorn, L.; Brisse, S. The population structure of Acinetobacter baumannii: Expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 2010, 5, e10034. [Google Scholar] [CrossRef]
  47. Sugawara, E.; Nikaido, H. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB- TolC system of Escherichia coli. Antimicrob. Agents Chemother. 2014, 58, 7250–7257. [Google Scholar] [CrossRef]
  48. Russo, T.A.; Luke, N.R.; Beanan, J.M.; Olson, R.; Sauberan, S.L.; MacDonald, U.; Schultz, L.W.; Umland, T.C.; Campagnari, A.A. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 2010, 78, 3993–4000. [Google Scholar] [CrossRef]
  49. Wyres, K.L.; Cahill, S.M.; Holt, K.E.; Hall, R.M.; Kenyon, J.J. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb. Genom. 2020, 6, e000339. [Google Scholar] [CrossRef]
  50. Loehfelm, T.W.; Luke, N.R.; Campagnari, A.A. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 2008, 190, 1036–1044. [Google Scholar] [CrossRef] [PubMed]
  51. Tomaras, A.P.; Dorsey, C.W.; Edelmann, R.E.; Actis, L.A. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system. Microbiology 2003, 149, 3473–3484. [Google Scholar] [CrossRef]
  52. Choi, A.H.K.; Slamti, L.; Avci, F.Y.; Pier, G.B.; Maira-Litrán, T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 2009, 191, 5953–5963. [Google Scholar] [CrossRef] [PubMed]
  53. Ronish, L.A.; Lillehoj, E.; Fields, J.K.; Sundberg, E.J.; Piepenbrink, K.H. The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili. J. Biol. Chem. 2019, 294, 218–230. [Google Scholar] [CrossRef]
  54. Wang, H.; Xu, Q.; Zhao, W.; Chan, B.K.W.; Chen, K.; Xie, M.; Yang, X.; Ni, H.; Chan, E.W.C.; Yang, G.; et al. Simultaneous functional disruption of the iron acquisition system and type VI secretion system results in complete suppression of virulence in Acinetobacter baumannii. Microbiol. Res. 2025, 295, 128105. [Google Scholar] [CrossRef]
  55. de Léséleuc, L.; Harris, G.; KuoLee, R.; Xu, H.H.; Chen, W. Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii. Int. J. Med. Microbiol. 2014, 304, 360–369. [Google Scholar] [CrossRef]
  56. Darby, E.M.; Moran, R.A.; Holden, E.; Morris, T.; Harrison, F.; Clough, B.; McInnes, R.S.; Schneider, L.; Frickel, E.M.; Webber, M.A.; et al. Differential development of antibiotic resistance and virulence between Acinetobacter species. mSphere 2024, 9, e0010924. [Google Scholar] [CrossRef]
  57. Chatterjee, S.; Datta, S.; Roy, S.; Ramanan, L.; Saha, A.; Viswanathan, R.; Som, T.; Basu, S. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: Focus on NDM-1 and its linkage to ISAba125. Front. Microbiol. 2016, 7, 1126. [Google Scholar] [CrossRef]
  58. Nowak, J.; Seifert, H.; Higgins, P.G. Prevalence of eight resistance-nodulation-division efflux pump genes in epidemiologically characterized Acinetobacter baumannii of worldwide origin. J. Med. Microbiol. 2015, 64, 630–635. [Google Scholar] [CrossRef] [PubMed]
  59. Marchand, I.; Damier-Piolle, L.; Courvalin, P.; Lambert, T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 2004, 48, 3298–3304. [Google Scholar] [CrossRef] [PubMed]
  60. Antunes, L.C.S.; Imperi, F.; Carattoli, A.; Visca, P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 2011, 6, e22674. [Google Scholar] [CrossRef] [PubMed]
  61. Espinal, P.; Pantel, A.; Rolo, D.; Marti, S.; López-Rojas, R.; Smani, Y.; Pachón, J.; Vila, J.; Lavigne, J.P. Relationship between different resistance mechanisms and virulence in Acinetobacter baumannii. Microb. Drug Resist. 2019, 25, 752–760. [Google Scholar] [CrossRef]
  62. Andersson, D.I.; Hughes, D. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat. Rev. Microbiol. 2010, 8, 260–271. [Google Scholar] [CrossRef]
  63. Ou, H.Y.; Kuang, S.N.; He, X.; Molgora, B.M.; Ewing, P.J.; Deng, Z.; Osby, M.; Chen, W.; Xu, H.H. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: Epidemiology, resistance genetic determinants and potential virulence factors. Sci. Rep. 2015, 5, 8643. [Google Scholar] [CrossRef] [PubMed]
  64. Parrow, N.L.; Fleming, R.E.; Minnick, M.F. Sequestration and scavenging of iron in infection. Infect. Immun. 2013, 81, 3503–3514. [Google Scholar] [CrossRef] [PubMed]
  65. Zimbler, D.L.; Penwell, W.F.; Gaddy, J.A.; Menke, S.M.; Tomaras, A.P.; Connerly, P.L.; Actis, L.A. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 2009, 22, 23–32. [Google Scholar] [CrossRef]
  66. Leighton, T.L.; Dayalani, N.; Sampaleanu, L.M.; Howell, P.L.; Burrows, L.L. Novel role for PilNO in type IV pilus retraction revealed by alignment subcomplex mutations. J. Bacteriol. 2015, 197, 2229–2238. [Google Scholar] [CrossRef] [PubMed]
  67. Harding, C.M.; Nasr, M.A.; Kinsella, R.L.; Scott, N.E.; Foster, L.J.; Weber, B.S.; Fiester, S.E.; Actis, L.A.; Tracy, E.N.; Munson, R.S.; et al. Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O-glycosylation of multiple proteins. Mol. Microbiol. 2015, 96, 1023–1041. [Google Scholar] [CrossRef]
  68. Piepenbrink, K.H.; Lillehoj, E.; Harding, C.M.; Labonte, J.W.; Zuo, X.; Rapp, C.A.; Munson, R.S.; Goldblum, S.E.; Feldman, M.F.; Gray, J.J.; et al. Structural diversity in the type IV pili of multidrug-resistant Acinetobacter. J. Biol. Chem. 2016, 291, 22924–22935. [Google Scholar] [CrossRef]
  69. Richmond, G.E.; Evans, L.P.; Anderson, M.J.; Wand, M.E.; Bonney, L.C.; Ivens, A.; Chua, K.L.; Webber, M.A.; Sutton, J.M.; Peterson, M.L.; et al. The Acinetobacter baumannii two-component system AdeRS regulates genes required for multidrug efflux, biofilm formation, and virulence in a strain-specific manner. mBio 2016, 7, e00430-16. [Google Scholar] [CrossRef]
  70. He, X.; Lu, F.; Yuan, F.; Jiang, D.; Zhao, P.; Zhu, J.; Cheng, H.; Cao, J.; Lu, G. Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump. Antimicrob. Agents Chemother. 2015, 59, 4817–4825. [Google Scholar] [CrossRef]
  71. King, L.B.; Swiatlo, E.; Swiatlo, A.; McDaniel, L.S. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol. Med. Microbiol. 2009, 55, 414–421. [Google Scholar] [CrossRef]
Figure 1. Growth kinetics and biofilm formation of A. baumannii laboratory strain ATCC 19606 and clinical isolate HKAB-1. (A) Growth curves of A. baumannii strains were fitted using the Baranyi and Roberts growth model without a lag phase. Shaded areas represent the 95% confidence intervals derived from bootstrapping. (B) Maximum specific growth rates (μmax) calculated from the fitted growth model. Statistical analysis was performed using an unpaired Student’s t-test. (C) Optical density at 600 nm (OD600) measured at the 5 h time point. Statistical analysis was performed using an unpaired Student’s t-test. (D) Growth curves of A. baumannii strains grown in MH2B and HKAB-1 strain grown in bovine serum albumin (serum) were fitted using the modified Gompertz growth model, while growth curve of ATCC 19606 grown in bovine serum albumin was fitted using the Baranyi and Roberts growth model without ymax. Shaded areas represent the 95% confidence intervals derived from bootstrapping. (E) Quantification of biofilm biomass formed by A. baumannii strains at 30 °C and 37 °C, stained with crystal violet. Data represent individual biological replicates (black dots) and the mean ± SEM from at least three independent biological experiments. Statistical analysis was performed using an unpaired Student’s t-test with Welch’s correction for unequal variances where applicable.
Figure 1. Growth kinetics and biofilm formation of A. baumannii laboratory strain ATCC 19606 and clinical isolate HKAB-1. (A) Growth curves of A. baumannii strains were fitted using the Baranyi and Roberts growth model without a lag phase. Shaded areas represent the 95% confidence intervals derived from bootstrapping. (B) Maximum specific growth rates (μmax) calculated from the fitted growth model. Statistical analysis was performed using an unpaired Student’s t-test. (C) Optical density at 600 nm (OD600) measured at the 5 h time point. Statistical analysis was performed using an unpaired Student’s t-test. (D) Growth curves of A. baumannii strains grown in MH2B and HKAB-1 strain grown in bovine serum albumin (serum) were fitted using the modified Gompertz growth model, while growth curve of ATCC 19606 grown in bovine serum albumin was fitted using the Baranyi and Roberts growth model without ymax. Shaded areas represent the 95% confidence intervals derived from bootstrapping. (E) Quantification of biofilm biomass formed by A. baumannii strains at 30 °C and 37 °C, stained with crystal violet. Data represent individual biological replicates (black dots) and the mean ± SEM from at least three independent biological experiments. Statistical analysis was performed using an unpaired Student’s t-test with Welch’s correction for unequal variances where applicable.
Biology 14 01201 g001
Figure 2. Desiccation tolerance and motility phenotypes of A. baumannii laboratory strain ATCC 19606 and clinical isolate HKAB-1. (A,B) Twitching motility was assessed using polystyrene petri dishes by inoculating bacterial cells at the agar–plastic interphase. The twitching zones were stained with crystal violet after incubation, and the diameters were measured. (C,D) Swarming motility was evaluated by spotting bacterial cultures onto the surface of semi-solid agar, followed by measurement of the swarming zone diameter. (B,D) Data represent individual biological replicates (black dots) and the mean ± SEM from at least three independent biological experiments. Statistical analysis was determined using an unpaired Student’s t-test. (E) Survival of A. baumannii ATCC 19606 and HKAB-1 strains under 20–25% relative humidity. Survival is expressed as the percentage of colony-forming units relative to day 0 (set as 100%). Data represent five biological replicates (n = 5), with standard errors shown as error bars. Statistical significance was assessed using Tukey’s honestly significant difference test (*, p < 0.05; ***, p < 0.005).
Figure 2. Desiccation tolerance and motility phenotypes of A. baumannii laboratory strain ATCC 19606 and clinical isolate HKAB-1. (A,B) Twitching motility was assessed using polystyrene petri dishes by inoculating bacterial cells at the agar–plastic interphase. The twitching zones were stained with crystal violet after incubation, and the diameters were measured. (C,D) Swarming motility was evaluated by spotting bacterial cultures onto the surface of semi-solid agar, followed by measurement of the swarming zone diameter. (B,D) Data represent individual biological replicates (black dots) and the mean ± SEM from at least three independent biological experiments. Statistical analysis was determined using an unpaired Student’s t-test. (E) Survival of A. baumannii ATCC 19606 and HKAB-1 strains under 20–25% relative humidity. Survival is expressed as the percentage of colony-forming units relative to day 0 (set as 100%). Data represent five biological replicates (n = 5), with standard errors shown as error bars. Statistical significance was assessed using Tukey’s honestly significant difference test (*, p < 0.05; ***, p < 0.005).
Biology 14 01201 g002
Figure 3. Schematic representation of (A) circular chromosome map of the draft genome of HKAB-1 generated through Proksee tool [35], including genome annotation and prophage from PHASTest [34], and (B) the core-genome phylogenetic tree of A. baumannii HKAB-1 and representative Acinetobacter strains. HKAB-1 clusters closely within the A. baumannii clade and is clearly separated from non-baumannii species such as A. pittii, A. junii, and A. tandoii.
Figure 3. Schematic representation of (A) circular chromosome map of the draft genome of HKAB-1 generated through Proksee tool [35], including genome annotation and prophage from PHASTest [34], and (B) the core-genome phylogenetic tree of A. baumannii HKAB-1 and representative Acinetobacter strains. HKAB-1 clusters closely within the A. baumannii clade and is clearly separated from non-baumannii species such as A. pittii, A. junii, and A. tandoii.
Biology 14 01201 g003
Figure 4. Gene expression analysis of RND efflux pumps and virulence-associated genes in A. baumannii HKAB-1 and ATCC 19606. ΔCT values were calculated as CT(rpoB) − CT(target gene). ΔΔCT values represent the mean difference in ΔCT between treatment and control samples (a positive ΔΔCT value indicates induction due to the treatment, while a negative ΔΔCT value indicates repression due to the treatment). The ΔCT of the tested genes in the x-axis represents the calculated ΔCT of the control samples. Points and error bars represent means and SEMs, respectively, of n ≥ 3 biological replicates. The SEMs shown were obtained as pooled estimates from the entire dataset. As the sizes of all samples are equal, the bars all have the same lengths. Statistical analysis using Tukey’s HSD test identified several genes with highly significant differences (p < 0.005). (A) Expression levels of RND genes in HKAB-1. Gene expression of RND genes in ATCC 19606 was used as control. A significant interaction between gene and treatment (HKAB-1) was observed using ANOVA [F(3, 12) = 396.70, p < 0.001; see Materials and Methods], indicating differential gene regulation among RND genes under the experimental conditions. Notably, adeB was significantly downregulated in HKAB-1 (ΔΔCT = −7.27 ± 0.21; fold change = 0.0065). (B) Expression levels of biofilm- and motility-associated genes in HKAB-1 (treatment) as compared to ATCC 19606 (control). A significant interaction between gene and treatment was observed using ANOVA [F(7, 28) = 34.04, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. Notably, bap, pilA, and pilO were significantly upregulated in HKAB-1 (bap: ΔΔCT = 3.03 ± 0.45; fold change = 8.14; pilA: ΔΔCT = 5.54 ± 0.45; fold change = 46.54; pilO: ΔΔCT = 2.42 ± 0.45; fold change = 5.34). (C) Expression levels of biofilm-associated genes in HKAB-1 biofilm (treatment) as compared to planktonic culture (control). A significant interaction between gene and treatment was observed using ANOVA [F(10, 40) = 125.67, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. Notably, adeB, adeG, bap, csuC, pgaB, pilA, and pilO were significantly upregulated in biofilm (adeB: ΔΔCT = 7.88 ± 0.43; fold change = 236.19; adeG: ΔΔCT = 7.54 ± 0.43; fold change = 185.98; bap: ΔΔCT = 2.06 ± 0.43; fold change = 4.17; basA: ΔΔCT = 6.05 ± 0.43; fold change = 66.43; bfnL: ΔΔCT = 3.84 ± 0.43; fold change = 14.33; pgaB: ΔΔCT = 5.55 ± 0.43; fold change = 46.79; pilA: ΔΔCT = 2.73 ± 0.43; fold change = 6.62; pilO: ΔΔCT = 3.77 ± 0.43; fold change = 13.60). (D) Expression levels of genes involved in heme acquisition and siderophore clusters in response to serum (treatment). Gene expression in MH2B was used as control. A significant interaction between gene and treatment was observed using ANOVA [F(4, 36) = 199.85, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. All tested genes were significantly upregulated upon serum exposure (basA: ΔΔCT = 4.32 ± 0.42, fold change = 19.96; bfnL: ΔΔCT = 6.05 ± 0.42, fold change = 66.29; hemO: ΔΔCT = 9.13 ± 0.42, fold change = 558.50; ACP71R_07005: ΔΔCT = 1.89 ± 0.42, fold change = 3.71).
Figure 4. Gene expression analysis of RND efflux pumps and virulence-associated genes in A. baumannii HKAB-1 and ATCC 19606. ΔCT values were calculated as CT(rpoB) − CT(target gene). ΔΔCT values represent the mean difference in ΔCT between treatment and control samples (a positive ΔΔCT value indicates induction due to the treatment, while a negative ΔΔCT value indicates repression due to the treatment). The ΔCT of the tested genes in the x-axis represents the calculated ΔCT of the control samples. Points and error bars represent means and SEMs, respectively, of n ≥ 3 biological replicates. The SEMs shown were obtained as pooled estimates from the entire dataset. As the sizes of all samples are equal, the bars all have the same lengths. Statistical analysis using Tukey’s HSD test identified several genes with highly significant differences (p < 0.005). (A) Expression levels of RND genes in HKAB-1. Gene expression of RND genes in ATCC 19606 was used as control. A significant interaction between gene and treatment (HKAB-1) was observed using ANOVA [F(3, 12) = 396.70, p < 0.001; see Materials and Methods], indicating differential gene regulation among RND genes under the experimental conditions. Notably, adeB was significantly downregulated in HKAB-1 (ΔΔCT = −7.27 ± 0.21; fold change = 0.0065). (B) Expression levels of biofilm- and motility-associated genes in HKAB-1 (treatment) as compared to ATCC 19606 (control). A significant interaction between gene and treatment was observed using ANOVA [F(7, 28) = 34.04, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. Notably, bap, pilA, and pilO were significantly upregulated in HKAB-1 (bap: ΔΔCT = 3.03 ± 0.45; fold change = 8.14; pilA: ΔΔCT = 5.54 ± 0.45; fold change = 46.54; pilO: ΔΔCT = 2.42 ± 0.45; fold change = 5.34). (C) Expression levels of biofilm-associated genes in HKAB-1 biofilm (treatment) as compared to planktonic culture (control). A significant interaction between gene and treatment was observed using ANOVA [F(10, 40) = 125.67, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. Notably, adeB, adeG, bap, csuC, pgaB, pilA, and pilO were significantly upregulated in biofilm (adeB: ΔΔCT = 7.88 ± 0.43; fold change = 236.19; adeG: ΔΔCT = 7.54 ± 0.43; fold change = 185.98; bap: ΔΔCT = 2.06 ± 0.43; fold change = 4.17; basA: ΔΔCT = 6.05 ± 0.43; fold change = 66.43; bfnL: ΔΔCT = 3.84 ± 0.43; fold change = 14.33; pgaB: ΔΔCT = 5.55 ± 0.43; fold change = 46.79; pilA: ΔΔCT = 2.73 ± 0.43; fold change = 6.62; pilO: ΔΔCT = 3.77 ± 0.43; fold change = 13.60). (D) Expression levels of genes involved in heme acquisition and siderophore clusters in response to serum (treatment). Gene expression in MH2B was used as control. A significant interaction between gene and treatment was observed using ANOVA [F(4, 36) = 199.85, p < 0.001; see Materials and Methods], indicating differential gene regulation under the tested conditions. All tested genes were significantly upregulated upon serum exposure (basA: ΔΔCT = 4.32 ± 0.42, fold change = 19.96; bfnL: ΔΔCT = 6.05 ± 0.42, fold change = 66.29; hemO: ΔΔCT = 9.13 ± 0.42, fold change = 558.50; ACP71R_07005: ΔΔCT = 1.89 ± 0.42, fold change = 3.71).
Biology 14 01201 g004
Table 1. Antimicrobial susceptibility of A. baumannii clinical isolate HKAB-1 and ATCC 19606.
Table 1. Antimicrobial susceptibility of A. baumannii clinical isolate HKAB-1 and ATCC 19606.
MIC (μg/mL)
HKAB-1ATCC 19606Antibiotics
Aminoglycosides
48–16Amikacin
1–216–32Gentamicin
0.52–4Tobramycin
Carbapenems
0.1250.5Doripenem
0.125–0.250.5–1Meropenem
Cephalosporins
8–1616Cefotaxime
32–6464–128Ceftriaxone
32–64128Cefuroxime
Fluoroquinolones
0.1251Ciprofloxacin
0.125–0.250.5Levofloxacin
Macrolides
2–432–64Azithromycin
16–3264–128Clarithromycin
816Erythromycin
Penicillins
16256Amoxicillin
512256Oxacillin
8–1632–64Piperacillin
Tetracyclines
0.251–2Doxycycline
0.1250.5Minocycline
2–416Tetracycline
0.125–0.254Tigecycline
Other antibiotics
64–12864–128Chloramphenicol
256–512256Clindamycin
256256Fusidic acid
256–512256–512Linezolid
>256128–256Nitrofurantoin
>1024>1024Fosfomycin
0.25–0.50.25–0.5Polymyxin B
42Rifampicin
10241024Sulfamethoxazole
32–6464–128Trimethoprim
256256–512Vancomycin
Table 2. Summary of sequence data and genome features of A. baumannii clinical isolate HKAB-1.
Table 2. Summary of sequence data and genome features of A. baumannii clinical isolate HKAB-1.
ValueMetrics
7,674,099 × 2Total number of reads sequenced
608.3Coverage
24Contig count (≥500 bp)
99.4Coarse consistency (%)
98.8Fine consistency (%)
100Completeness (%)
0.2Contamination (%)
3,758,367Genome size (bp)
365,067Contigs N50 (bp)
4Contigs L50
38.92Guanine-cytosine content (%)
3559Number of genes
3488Number of coding sequences (CDSs)
63Number of tRNAs
4Number of rRNAs
Table 3. Predicted antimicrobial resistance of A. baumannii clinical isolate HKAB-1.
Table 3. Predicted antimicrobial resistance of A. baumannii clinical isolate HKAB-1.
Antibiotic Resistance
% IdentityProtein FamilyGeneLocus Tag
Antibiotic inactivation
98.75β-lactamaseblaOXA-91ACP71R_01635
100.00β-lactamaseblaADC-50ACP71R_02890
99.71β-lactamaseblaMBLACP71R_06460
98.79β-lactamaseblaOXA-51ACP71R_07365
97.48β-lactamaseblaAACP71R_08870
98.61Aminoglycoside nucleotidyltransferaseant(3)-IIaACP71R_14580
Efflux pumps and its regulator
99.38Resistance nodulation cell divisionadeKACP71R_01165
99.59Resistance nodulation cell divisionadeJACP71R_01170
99.92Resistance nodulation cell divisionadeIACP71R_01175
99.17Resistance nodulation cell divisionadeHACP71R_03190
97.23Resistance nodulation cell divisionadeGACP71R_03195
98.85Resistance nodulation cell divisionadeFACP71R_03200
99.21Transcription regulatoradeLACP71R_03205
99.70Small multidrug resistanceabeSACP71R_03230
97.84Major facilitator superfamilyamvAACP71R_04480
98.47Transcription regulatoradeNACP71R_04740
98.85Major facilitator superfamilyabaQACP71R_05490
97.49Resistance nodulation cell divisionadeT1ACP71R_05965
97.33Two-component signal transduction systemadeSACP71R_05975
98.66Two-component signal transduction systemadeRACP71R_05980
98.66Resistance nodulation cell divisionadeAACP71R_05985
98.23Resistance nodulation cell divisionadeBACP71R_05990
97.75Major facilitator superfamilyabaFACP71R_08510
98.89Transcription regulatormexTACP71R_10620
98.52Multi-antimicrobial extrusion proteinabeMACP71R_13360
100.00Major facilitator superfamilycraAACP71R_16955
99.58Resistance nodulation cell divisionadeT2ACP71R_17230
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Foong, W.E.; He, W.; Xiang, X.; Huang, J.; Tam, H.-K. Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance. Biology 2025, 14, 1201. https://doi.org/10.3390/biology14091201

AMA Style

Foong WE, He W, Xiang X, Huang J, Tam H-K. Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance. Biology. 2025; 14(9):1201. https://doi.org/10.3390/biology14091201

Chicago/Turabian Style

Foong, Wuen Ee, Wenjun He, Xinxin Xiang, Jiabin Huang, and Heng-Keat Tam. 2025. "Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance" Biology 14, no. 9: 1201. https://doi.org/10.3390/biology14091201

APA Style

Foong, W. E., He, W., Xiang, X., Huang, J., & Tam, H.-K. (2025). Genomic and Phenotypic Characterization of a Drug-Susceptible Acinetobacter baumannii Reveals Increased Virulence-Linked Traits and Stress Tolerance. Biology, 14(9), 1201. https://doi.org/10.3390/biology14091201

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop